STEMart announces the expansion of its genetic toxicology capabilities with the In Vivo Rat Micronucleus Test services.

Medical device manufacturers use cytotoxicity testing to help prove that devices that come into contact with the human body are biocompatible. Testing results are critical for gaining market access, ...

Cellulose dermal filler achieves critical biocompatibility milestones, paving the way for clinical trials OTTAWA, ON, April 29, 2025 /PRNewswire/ - Spiderwort Biotechnologies Inc., a pioneering ...

BOENNIGHEIM, Germany and LIGONIER, Ind., Nov. 4, 2025 /PRNewswire/ -- Hohenstein Medical – a division of Hohenstein Laboratories and a leading provider of testing, research and certification services ...

In the test, the chemicals leaching off of the device are compared with a searchable database that provides background on toxicity and the Cramer classification. The proposed change in the standard ...

The cryopreservation of red blood cells (RBCs) holds great potential for ensuring timely blood transfusions and maintaining an adequate RBC inventory. Cryoprotectants (CPAs) are a series of ...

As regulatory scrutiny over device biocompatibility increases, MCRA forms a world class team of biocompatibility experts from FDA and industry. Key hires Eric M. Sussman, PhD, and Claus Svane ...

OTTAWA, ON, April 29, 2025 /PRNewswire/ - Spiderwort Biotechnologies Inc., a pioneering biotechnology company focused on cellulose-based regenerative medicine, today announced the completion of ISO ...